The utilization of an index for serum globulin compensation in diseases associated with decreased serum albumin

Medical Journal of Malaysia

Volumn 59, Issue 4, 2004, Pages 495-501

  Al Joudi, Fawwaz S ^a   Wahab, N A ^a  

^a SCHOOL OF PHYSICS   (Malaysia)

Author keywords

Decreased serum albumin; Globulin compensation index; Serum globular proteins

Indexed keywords

SERUM ALBUMIN; SERUM GLOBULIN;

ARTICLE; BLOOD; HUMAN; KIDNEY DISEASE; RETROSPECTIVE STUDY;

HUMANS; KIDNEY DISEASES; RETROSPECTIVE STUDIES; SERUM ALBUMIN; SERUM GLOBULINS;

EID: 18244388732     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Clinical Diagnosis and Management by Laboratory Methods, 19th Edition, 1996, Ed. Henry, JB, WB Saunders Company.
2. Dufour DR, Lott JA, Fredrick SN, Gretch DR, Koff RS, and Seeff LB, Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis and monitoring, Clin Chem, 2000; 46 (12): 2050-68.
3. Podolsky DK and Isselbacher KJ, Derangements of hepatic metabolism, in Harrison's Principles of Internal Medicine, Vol II, Editors Wilson, JD et al., 12th edition, 1991, McGraw Hill.
4. Pratt DS and Kaplan MM, Evaluation of liver function, in Harrison's Principles of Internal Medicine, Vol. II, Editors Braunwald, E, et al. 15th edition, 2001, McGraw Hill.
5. Goldwasser P and Feldman J, Association of serum albumin and mortality risk, J Clin Epidemiol, 1997; 50 (6): 693-703.
6. Feldman JG, Burns DN, Gange SG, Bacchetti P, Cohen M, Anastos K, Nowicki M, Delapena R and Miotti P, Serum albumin as a predictor of survival in HIV-infected women in the Women's Interagency HIV study, AIDS, 2000; 14 (7): 863-70.
7. Reuben DB, Ferrucci, L, Wallace R, Tracy RP, Corti MC, Heimovitz H and Harris TB, The prognostic value of serum albumin in healthy older persons with low and high interleukin-6 (IL-6) levels, J Am Geriatr Soc, 2000; 48 (11): 1404-7.
8. Rzany B, Partscht K, Jung M, Kippes W, Mecking D, Baima B, et al., Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticoids, and old age, Arch Dermatol, 2002; 138 (7): 903-8.
9. Bruille D, Rose F, Arna M, Melin C and Obled C, Sepsis modifies the contribution of different organs to whole-body protein synthesis in rats, Clin Sci (Lond), 1994; 86 (6): 663-9.
10. Pisters PW and Brennen MF, Amino acid metabolism in human cancer cachexia, Am Rev Nutr, 1990; 10: 107-32.
11. Inui A, Cancer anorexia-cachexia syndrome: current issues in research and management, CA Cancer J Clin, 2002; 52 (2): 72-91.
12. Tisdale MJ, Loss of skeletal muscle in cancer: biochemical mechanisms, Front Biosci, 2001; 6: D164-74.
13. Wigmore SJ, Todorov PT, Barber, MD, Ross JA, Tisdale MJ and Fearon, KC, Characteristics of patients with pancreatic cancer expressing a novel cancer cachectic factor, Br J Surg, 2000; 87 (1): 53-8.
14. Mercier S, Bruille D, Mosoni L, Obled C and Patureau Mirand P, Chronic inflammation alters protein metabolism in several organs of adult rats, J Nutr, 2002; 132 (7): 1921-8.
15. Cogo PE, Carnielli VP, Rosso F, Cesarone A, Giordano G, Faggian D, Plebani M, Barreca A and Zacchello F, Protein turnover, lipolysis and endogenous hormonal secretion in critically ill children, Crit Care Med, 2002; 30 (10): 252-3.
16. Barber MD, Fearon KC, McMillan DC, Slater C, Rossa JA and Preston, T, Liver export protein synthetic rates are increased by oral meal feeding in weight-losing cancer patients, Am J Physiol Endocrinol Metab, 2000; 279 (3): E707-14.
17. Fearon, KC, Falconer JS, Slater C, McMillan DC, Ross JA, and Preston T, Albumin synthesis rates are not decreased in hypoalbuminemic cachectic cancer patients with an ongoing acute-phase protein response, Ann Surg, 1998; 227 (2): 249-54.
18. Gadducci A, Cosio S, Fauncchi A and Genazzani AR, Malnutrition and cachexia in ovarian cancer patients: pathophysiology and management, Anticancer res, 2001; 21 (4B(: 2941-7.
19. Coletti D, Yang E, Marazzi G, and Sasson D, TNFalpha inhibits skeletal muscle myogenesis through a PW1-dependant pathway by recruitment of caspase pathways, EMBO J, 2002; 21 (4): 631-42.
20. Carbo N, Busquets S, van Royen M, Alvarez B, Lopez-Soriano FJ and Argiles JM, TNF-alpha is involved in activating DNA fragmentation in skeletal muscle, Br J Cancer, 2002; 86 (6): 1012-6.
21. Barber MD, Ross JA and Fearon KC, Changes in nutritional, functional, and inflammatory markers in advanced pancreatic cancer, Nutr Cancer, 1999; 35 (20): 106-10.